OQS
CTIC

Occudo Quantitative Strategies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Occudo Quantitative Strategies’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-68,516
Closed -$399K – 1515
2022
Q3 		$399K Sell
68,516
-138,438
-67% -$863K 0.03% 749
2022
Q2 		$1.24M Buy
206,954
+125,013
+153% +$640K 0.1% 310
2022
Q1 		$383K Buy
+81,941
New +$244K 0.03% 736
2021
Q3 		– Sell
-55,555
Closed -$139K – 1225
2021
Q2 		$139K Sell
55,555
-4,993
-8% -$12K 0.02% 767
2021
Q1 		$176K Buy
60,548
+49,666
+456% +$162K 0.04% 646
2020
Q4 		$35K Buy
+10,882
New +$36.2K 0.01% 625

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Occudo Quantitative Strategies's CTIC Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2022, closing a stake of 68,516 shares — an estimated $399K sold.

Occudo Quantitative Strategies first reported a position in CTIC in Q4 2020 and held it in 6 quarters. The position peaked at $1.24M in Q2 2022. 145 funds tracked by Wall St. Rank hold CTIC as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 68,516 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2022, an estimated $399K.
  • Occudo Quantitative Strategies first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2020 and held it in 6 quarters.
  • Occudo Quantitative Strategies's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.24M in Q2 2022.
  • 145 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.